Speaker
Samuele De Zan
(Università degli studi di Padova)
Summary
Targeted radionuclide therapy has demonstrated efficacy in patients with metastatic cancer. Hence, the selection of the radionuclide is fundamental for the therapy outcomes. The aim of this study was to assess the impact of the nuclear properties of six β⁻-emitting radionuclides on the dosimetric outcomes of two TRT RPs, with distinct pharmacokinetics. This approach contributes to the advancement of personalized TRT for effective treatment.
| Are you interested/eligible for the Young Session? | Yes, I am eligible and interested in participating |
|---|
Author
Samuele De Zan
(Università degli studi di Padova)
Co-authors
Ekaterina Dadachova
(University of Saskatchewan)
Gulliermina Ferro-Flores
(Instituto Nacional de Investigaciones Nucleares)
Kevin J. H. Allen
(University of Saskatchewan)
Laura De Nardo
(Università degli studi di Padova)
Laura Melendez-Alafort
(Istituto Oncologico Veneto - IRCCS)
